日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Quemliclustat联合化疗(加或不加zimberelimab)治疗转移性胰腺腺癌:一项随机1期试验

Wainberg, Zev A; Manji, Gulam A; Bahary, Nathan; Ulahannan, Susanna V; Pant, Shubham; Spigel, David R; Uboha, Nataliya V; Oberstein, Paul E; Saeed, Anwaar; Beagle, Brandon; Kim, Ji Yun; Wang, Ning; Weeder, Ben; Shitole, Shravani; Mrouj, Karim; Scott, Jennifer R; Ensign, Lisa G; DiRenzo, Daniel M; Walters, Matthew J; Wu, Wilson; Kaplan, Angelo; Cho, Soonweng; Kabbarah, Omar; O'Reilly, Eileen M

INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INDUCE-3:一项随机 II/III 期研究,评估一线 Feladilimab 联合 Pembrolizumab 治疗复发/转移性头颈部鳞状细胞癌患者的疗效

Rischin, Danny; Hansen, Aaron R; Cohen, Ezra E W; Tahara, Makoto; Harrington, Kevin J; Haddad, Robert I; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J; Washburn, Michael L; Phillips-Jones, Amy; Russell, John; Roy-Ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)

快速实时评估免疫肿瘤学联合疗法在晚期非小细胞肺癌患者中的应用(FRACTION-Lung)

He, K; Forde, P M; Govindan, R; Santoro, A; Gettinger, S; Borghaei, H; Spira, A; Chu, Q; Zinner, R; Schoenfeld, A J; Camidge, D R; Spigel, D R; Gurpide, A; Juergens, R A; Laurie, S A; Cerra, M; Spires, T; Greenawalt, D M; Rapoport, I; Gainor, J F

Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices

转移性非小细胞肺癌患者的生物标志物检测率和模式:一项社区实践中的前瞻性观察研究

Evangelist, Makenzi; Wang, Bo; Butrynski, James E; Paschold, John; Ward, Patrick J; Waterhouse, David M; Jotte, Robert M; Ali, Kashif; Richards, Donald A; Konduri, Kartik; Melnyk, Anton; Owera, Rami S; Hakimian, David; Ghaddar, Habib; Lander, Eric M; Robert, Nicholas J; Yori, Jennifer L; Upadhyay, Vikalp; Spigel, David R; Johnson, Melissa L

Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up

替雷利珠单抗联合化疗治疗胃癌:RATIONALE-305随机试验的长期随访

Cruz-Correa, Marcia; Oh, Do-Youn; Kato, Ken; Tabernero, Josep; Bai, Yuxian; Shi, Jianhua; Lee, Keun-Wook; Hirano, Hidekazu; Spigel, David; Wyrwicz, Lucjan; Pazo Cid, Roberto; Cubillo Gracián, Antonio; Xu, Yaling; Sheng, Tao; Yang, Silu; Xu, Rui-Hua; Moehler, Markus

Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trial

社区招募和包容性举措对生物标志物驱动的 MyTACTIC 试验入组的影响

Zuniga, Richard M; VanderWalde, Ari; Schwartzberg, Lee S; Spigel, David R; Passler, Luke; Hong, Jason; Howland, Michael; Darbonne, Walter C; Szado, Tania; Daniel, Davey

Cultural Brokering in Pregnancy Care: A Qualitative Study

孕期保健中的文化中介:一项定性研究

Spigel, Lauren; Bazan, Maria; Karlage, Ami; Schoenherr, Karen; DiMeo, Amanda; Chakraborty, Saugata; Molina, Rose L

Assessing the association between the domains of the Atlas Context Assessment and implementation outcomes of the TeamBirth project: a cross-sectional study

评估 Atlas 背景评估领域与 TeamBirth 项目实施结果之间的关联性:一项横断面研究

Westgard, Christopher M; Spigel, Lauren; Neergheen, Vanessa L; Eum, Ki-Do; Woodbury, Sam; Karlage, Ami; Lipsitz, Stuart; Maloney, Francine L; Short, Trisha; Weiseth, Amber; Berry, William; Elam, Meagan

TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.

TNG260 是一种小分子 CoREST 抑制剂,可使 STK11 突变肿瘤对 PD-1 抗肿瘤免疫疗法敏感。

Ahronian Leanne G, Sahu Soumyadip, Zhang Minjie, Patel Ayushi S, Geng Ke, Bhattacharya Reshmee, Falchook Gerald S, Goldman Jonathan W, Spira Alexander I, Punekar Salman R, Spigel David R, Wang Judy S, Skoulidis Ferdinandos, Stephens Janaye, Meynardie Mary, Powell Jaylen M, Lopez Alfonso, Ranieri Michela, Ploszaj Magdalena A, Tan Yi Jer, Lee Yeuan Ting, Yu Yi, Deng Jiehui, Chen Ting, McCarren Patrick, Tsai Alice, Hussain Suleman S, Doyon Brian, Amemiya Kenjie, Ermolieff Jacques, Shahagadkar Preksha, Das Nikitha M, Flynn Lauren R, Shields Julie A, Danielczyk Laney, McMillan Brian J, Mignault Andre, Meier Samuel R, Wu Hsin-Jung, Guerin David J, Whittington Douglas A, Min Chengyin, Sienczylo Iga, Maxwell John P, DiBenedetto Heather J, Watanabe Hideo, Haines Brian B, Huang Alan, Crystal Adam, Andersen Jannik N, Wu Xinyuan, Wong Kwok-Kin

ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial

ERBB2扩增型结直肠癌的ctDNA分析:MyPathway试验的生物标志物分析

Meric-Bernstam, Funda; Raghav, Kanwal Pratap Singh; Sweeney, Christopher J; Swanton, Charles; Spigel, David R; Bose, Ron; Burris, Howard A; Friedman, Claire F; Espenschied, Carin R; Grindheim, Jessica M; Malato, Julia; Schulze, Katja; Price, Richard; Kurzrock, Razelle